Biosimilars in the EU - Information guide for healthcare professionals

On October 29, 2019 EMA and EC updated the guide on biosimilars in the EU. This guide was first published in May 2017.

The European Medicines Agency (EMA) and the European Commission (EC) have developed information materials on biosimilar medicines to improve understanding of these medicines in the EU. They have published an information guide to provide reference information on the science and regulation underpinning the use of biosimilar medicines.

In addition, an information guide for patients published by the EC explains in a clear, unbiased way what biosimilar medicines are, how they are developed and approved in the EU and what patients can expect in terms of availability and safety. EMA and organizations representing patients contributed to the development of this guide. It is available in 23 official EU languages on the EC’s website.

Read the pdf
Copyright Widler & Schiemann AG 2015. All Rights Reserved. /